ERO1A and pancreatic neoplasm: The transwell assay without coated Matrigel suggested that ERO1L knockdown significantly inhibited pancreatic cancer cell migration (Figure 2(a)), whereas the transwell assay with coated Matrigel suggested that ERO1L knockdown significantly suppressed pancreatic cancer cell invasion (Figure 2(b)).